Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Leases (2019 - 2020)

Historic Leases for Larimar Therapeutics (LRMR) over the last 2 years, with Q3 2020 value amounting to $4.1 million.

  • Larimar Therapeutics' Leases fell 4291.69% to $4.1 million in Q3 2020 from the same period last year, while for Sep 2020 it was $4.1 million, marking a year-over-year decrease of 4291.69%. This contributed to the annual value of $87000.0 for FY2019, which is N/A changed from last year.
  • As of Q3 2020, Larimar Therapeutics' Leases stood at $4.1 million, which was down 4291.69% from $4.3 million recorded in Q2 2020.
  • Larimar Therapeutics' Leases' 5-year high stood at $7.3 million during Q2 2019, with a 5-year trough of $87000.0 in Q4 2019.